Hormone therapy with estradiol, delivered through a skin patch or gel, is the most reliable way to raise estrogen levels during perimenopause. But “increasing estrogen” is not always the right framing for what your body actually needs during this transition, because perimenopause is defined less by low estrogen than by wildly unpredictable estrogen. The picture is messier than a simple decline, and the strategies that help range from prescription hormones to dietary shifts to gut health, each targeting a different piece of the puzzle.
Why Estrogen Becomes Unpredictable Before It Drops
Perimenopause often gets described as “estrogen declining,” but that oversimplifies what is happening. Estrogen levels during this phase swing erratically, sometimes spiking higher than they did during your reproductive years, sometimes crashing. These fluctuations affect insulin production, glucose metabolism, and fat distribution, and the instability itself drives many classic symptoms like hot flashes, mood changes, and disrupted sleep.
The goal of treatment during perimenopause is not always to push estrogen higher. Sometimes it is to stabilize levels that are whipsawing. Sometimes it is to replace estrogen that has genuinely bottomed out. And sometimes it is to address specific symptoms in specific tissues without changing your whole-body hormone balance at all. The right approach depends on what your symptoms are and where you are in the transition.
Hormone Therapy and Why Delivery Method Matters
Prescription estrogen therapy remains the most effective tool for restoring estrogen levels and relieving perimenopausal symptoms. But how you take estrogen matters almost as much as whether you take it. The two main routes are oral (a pill) and transdermal (a patch, gel, or spray applied to the skin), and the safety profiles differ in one important way.
When you swallow estrogen, it passes through the liver before reaching the rest of your body. That first pass through the liver triggers changes in clotting factors that raise the risk of blood clots. Transdermal estrogen bypasses the liver entirely, delivering more consistent hormone levels into the bloodstream with a lower risk of clot-related complications.
A systematic review comparing oral and transdermal hormone therapy found clear evidence that blood clot risk is higher with the oral route, while other outcomes like bone density, glucose metabolism, lipid changes, breast cancer risk, and cardiovascular risk did not differ between the two routes.
The numbers on clot risk are striking. A meta-analysis found that oral estrogen carried roughly 60% higher risk of a first blood clot compared to transdermal estrogen.
One randomized trial of perimenopausal women found that transdermal estradiol paired with micronized progesterone reduced hot flashes by about 82%, compared to about 77% with oral regimens and 43% with non-hormonal therapy. The transdermal group also had substantially lower rates of blood clots.
A separate study looking specifically at oral versus transdermal estrogen found that the adjusted odds of blood clots in oral users were roughly four times those of transdermal users, while transdermal estrogen showed no increased clot risk compared to non-users at all.
For these reasons, transdermal delivery has become the preferred starting point for many clinicians, particularly for women with additional clot risk factors like obesity, smoking history, or a family history of blood clots.
Why Progesterone Comes With the Prescription
If you have a uterus and take estrogen, you need progesterone or a progestogen alongside it. Estrogen alone stimulates the uterine lining to grow, and over time that increases the risk of endometrial hyperplasia and cancer. Progesterone counteracts that proliferative effect.
The choice of progesterone type matters. Micronized progesterone, which is chemically identical to what your body produces, appears safer for breast tissue than synthetic progestins. However, research suggests it may be somewhat less effective at protecting the endometrium than synthetic options.
Your prescriber will help you weigh these trade-offs based on your risk profile. The key point is that estrogen therapy is not a solo act if you still have your uterus. Skipping the progesterone component is not an option.
Vaginal Estrogen for Localized Symptoms
Not every perimenopausal estrogen problem is a whole-body problem. Vaginal dryness, painful sex, urinary tract infections, and urinary incontinence are driven by estrogen loss in a specific area, and they respond well to estrogen applied directly to the vaginal tissue.
Vaginal estrogen comes as creams, tablets, suppositories, and rings. These preparations deliver estrogen right where it is needed and absorb very little into the bloodstream. A systematic review found that the various vaginal estrogen preparations had similar effectiveness and safety, and that blood estradiol levels stayed within the normal postmenopausal range for all except high-dose conjugated estrogen cream.
A smaller study of low-dose vaginal estrogen found significant improvement in vaginal symptoms after just four weeks, with further gains at twelve weeks. Blood estrogen levels barely changed during treatment, confirming that the effect stays local.
Vaginal estrogen is often prescribed on its own, without the need for progesterone, because the systemic absorption is so minimal. It is also an option for some women who cannot use systemic hormone therapy, though that decision involves a conversation with a clinician about individual risk.
Phytoestrogens and What Food Can (and Cannot) Do
Soy isoflavones are plant compounds structurally similar to human estrogen. They bind to estrogen receptors in the body and exert a weak estrogenic effect, which has made them one of the most studied dietary approaches to menopause symptoms. When your own estrogen levels are low, isoflavones can partially fill the gap. When estrogen is high, they compete for receptor binding and may actually dampen the effect of excess estrogen.
That dual action sounds appealing, but the evidence for meaningful symptom relief is modest. Soy isoflavones can reduce hot flash frequency to some degree, though the effect is considerably smaller than what hormone therapy achieves. They are not going to replace a prescription estradiol patch. Think of them more as a gentle nudge than a strong push.
Other dietary phytoestrogens include lignans (found in flaxseed), coumestans (in alfalfa sprouts and split peas), and various compounds in red clover. Red clover has attracted research attention because it contains isoflavones similar to soy’s, but the data on whether it meaningfully changes estrogen levels is unconvincing. A meta-analysis of red clover trials found a trend toward slightly higher estradiol levels in the red clover group compared to placebo, but the difference did not reach statistical significance.
A randomized trial that tested both black cohosh and red clover against placebo found that hormone levels did not change in any of the botanical groups, only in the group receiving conventional hormone therapy. Neither supplement raised safety concerns, but neither moved the needle on estrogen either.
The honest summary: phytoestrogen-rich foods are a reasonable addition to your diet and are unlikely to cause harm, but they are not a substitute for hormone therapy if your symptoms are significant.
Your Gut Bacteria and Estrogen Recycling
One of the more surprising players in estrogen balance is the gut microbiome. A collection of bacterial genes in the gut, called the estrobolome, produces enzymes that affect how your body recycles estrogen. After your liver processes estrogen and sends it to the intestines for excretion, gut bacteria can “deconjugate” it, essentially freeing it to be reabsorbed into your bloodstream rather than eliminated.
Research has confirmed that the gene copies for these enzymes are more abundant in premenopausal women, and that their activity correlates with both stool and blood estrogen levels.
What does this mean practically? A diverse, healthy gut microbiome may help your body hold onto more of the estrogen it produces, while a disrupted microbiome might let more estrogen slip away. Eating a fiber-rich diet, consuming fermented foods, and avoiding unnecessary antibiotics are standard recommendations for gut health that may have a secondary benefit for estrogen balance. The research here is still emerging, and nobody can yet tell you exactly which probiotic strain will boost your estrogen levels. But the connection between gut health and hormone metabolism is real and increasingly well-documented.
Exercise, Body Fat, and Estrogen Production
After the ovaries slow down, fat tissue becomes the primary site where estrogen is produced. An enzyme in fat cells converts other hormones into estrogen through a process called aromatization. This means body composition plays a role in how much estrogen circulates in your system.
The relationship is not straightforward, though. Having more body fat does mean more aromatization and higher estrogen levels, but it also comes with its own set of health risks. The goal is not to gain weight to boost estrogen. Rather, the relationship between exercise, fat, and hormones is more nuanced than that.
A randomized trial found that exercise-related fat loss was associated with changes in sex hormone levels in postmenopausal women, and that exercise may be an effective way to produce favorable shifts in these hormones.
A separate study comparing aerobic and resistance exercise in postmenopausal women found that both types improved estradiol levels. Interestingly, resistance training appeared to have a more potent effect on estradiol and lean mass than aerobic exercise alone, despite fewer total exercise sessions.
The take-home is that regular physical activity, particularly strength training, supports hormone health during and after the menopausal transition. The mechanism involves shifts in body composition and improved metabolic function rather than simply “making more estrogen.”
When You Start Matters More Than You Might Think
For years, the conversation about hormone therapy was clouded by fears from a large study in the early 2000s that linked it to cardiovascular risks. What has become clearer since then is that the timing of when hormone therapy begins makes a significant difference in safety and benefit.
The “timing hypothesis” holds that estrogen therapy started within about ten years of menopause, or before age sixty, carries low cardiovascular risk and may even slow the progression of atherosclerosis. Evidence from multiple randomized trials supports this window.
For women already experiencing perimenopausal symptoms, this is encouraging news. Starting hormone therapy during the transition or shortly after your final period falls squarely within the favorable window. Waiting until your mid-sixties to begin is a different risk-benefit calculation entirely, and current evidence does not support initiating systemic hormone therapy that late for symptom management.
This does not mean hormone therapy prevents heart disease. Current data does not support using it for that purpose. But for women in the right age window who want symptom relief, the cardiovascular risk appears to be low.
Non-Hormonal Options That Do Not Raise Estrogen
Some women cannot or prefer not to use estrogen. Breast cancer survivors, women with a history of blood clots, and those with certain other conditions may need non-hormonal alternatives. These approaches do not increase estrogen, but they can effectively treat the symptoms caused by estrogen loss, particularly hot flashes.
The most notable recent development is fezolinetant, an FDA-approved non-hormonal medication that targets the brain’s thermoregulatory system rather than replacing hormones. It blocks a specific receptor involved in triggering hot flashes and has shown substantial results in clinical trials. Roughly 81 to 95% of participants taking fezolinetant experienced at least a 50% reduction in hot flash frequency from baseline.
Older non-hormonal options include certain antidepressants (particularly SSRIs and SNRIs), gabapentin, and clonidine, which can all reduce hot flash frequency to varying degrees. None of these raise estrogen levels, but for women whose primary complaint is vasomotor symptoms, they can provide real relief.
Why Blood Tests Are Less Useful Than You’d Expect
Many women assume that a blood test can tell them exactly where they stand hormonally during perimenopause. In reality, hormone testing during this phase is surprisingly unhelpful. Estrogen levels swing so dramatically from day to day, even hour to hour, that a single blood draw is like taking a snapshot of a roller coaster and trying to describe the whole ride.
Current data does not support the idea that lab tests can predict the exact timing of your final menstrual period, and there is limited evidence that they add much predictive value beyond simply tracking your age and menstrual cycle patterns. A clinician who knows your symptom history and bleeding patterns will often have a better read on where you are in the transition than any lab panel.
This does not mean testing is never useful. Thyroid levels, for instance, should be checked because thyroid disorders can mimic perimenopausal symptoms. And in certain clinical situations, hormone levels can help rule out other conditions. But “test my estrogen” is rarely the clarifying move women hope it will be during perimenopause.
Compounded Bioidenticals Versus FDA-Approved Products
The term “bioidentical” has become a marketing buzzword, but it has a straightforward meaning: hormones that are chemically identical to those your body produces. Many FDA-approved hormone therapy products already are bioidentical. Estradiol patches, gels, and sprays contain the same molecule your ovaries make. So does micronized progesterone.
Compounded bioidentical hormones are mixed by compounding pharmacies, often in custom doses or combinations. They have a loyal following, but they come with a catch: compounded products are not subject to the same regulatory oversight as FDA-approved ones. Quality, consistency, and purity can vary from batch to batch and pharmacy to pharmacy.
A systematic review of compounded bioidentical hormone therapy found that the trends in absorption and effect were generally consistent with published data from FDA-approved products. In other words, the hormones themselves work similarly. The concern is not the molecule but the manufacturing process. If an FDA-approved bioidentical product at a standard dose meets your needs, it offers the same hormone with tighter quality control. Compounding has a role when a woman needs a specific dose, combination, or delivery form that is not commercially available, but it should not be the default choice simply because it is marketed as more “natural.”
Xenoestrogens and Estrogen Mimics to Watch Out For
While you may be looking for ways to boost your own estrogen, you are likely already being exposed to synthetic chemicals that mimic estrogen in unwanted ways. Xenoestrogens are found in certain plastics, pesticides, personal care products, and industrial chemicals. They are structurally similar enough to natural estrogen that they can bind to estrogen receptors throughout the body.
The concern with xenoestrogens is not that they helpfully supplement your declining estrogen. They bind to receptors in unpredictable patterns, potentially disrupting normal signaling in the brain and other tissues.
Reducing exposure involves practical steps: avoiding heating food in plastic containers, choosing personal care products free of parabens and phthalates, filtering drinking water, and eating organic produce when possible. These measures will not meaningfully change your estrogen levels, but they may reduce the interference from compounds that hijack your estrogen receptors without providing the benefits of real estrogen.
Sleep, Melatonin, and the Estrogen Connection
Estrogen does more than regulate your reproductive system. It influences sleep architecture, and the disrupted sleep that plagues many perimenopausal women is not just about night sweats waking you up. Estrogen helps modulate the sleep-wake cycle at a neurological level.
Research has found that postmenopausal women have lower nighttime melatonin levels and shorter melatonin secretion duration compared to perimenopausal women, suggesting that the loss of ovarian hormones may directly suppress melatonin output.
This creates a vicious feedback loop: poor sleep worsens mood, fatigue, and cognitive symptoms that are already driven by hormone fluctuations, and the hormone fluctuations themselves make sleep harder. Addressing estrogen levels through hormone therapy often improves sleep quality as a secondary benefit, which is one of the reasons women on hormone therapy frequently report feeling better overall even when hot flashes were not their primary complaint. For women not using hormone therapy, prioritizing sleep hygiene and discussing melatonin supplementation with a clinician can help blunt this particular aspect of the transition.